Keyword: licensing and development

News

Actelion Shakes Up Board, Appoints COO

07.06.2011 - Actelion, Europe's largest biotech company which has been under pressure from activist investor Elliott Advisors, is changing its management structure, including appointing a chief...

News

Some Key Facts On The Actelion Vs. Asahi Case

04.05.2011 - Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...

News

Pressure On Actelion Rises After Asahi Case Decision

02.05.2011 - Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...

News

Asahi Awarded Up To $547 Million In Actelion Case

02.05.2011 - Swiss biotech group Actelion may appeal against a jury's decision in a Californian court to award Asahi Kasei Pharma Corporation up to $547 million in a dispute with Actelion unit...